BAKER BROS. ADVISORS LP

Average Profitability
14.94%
Insider Buys Quantity
119
Insider Buys Sum
$4.09B
Insider Sells Quantity
23
Insider Sells Sum
$646.86M

Insider Activity of BAKER BROS. ADVISORS LP

According to the SEC Form 4 filings, BAKER BROS. ADVISORS LP, being in a position of

  1. at BeiGene, Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 1100000 shares for $198.55M,
    over all time since 2016-02-08, has bought 23287058 shares for $1.89B, and sold 2732700 shares for $558.56M.

The largest purchase of all time was on 2018-08-02 and amounted to 11628200 shares of BeiGene, Ltd. for $1.26B.

The largest sale of all time was on 2020-12-04 and amounted to 1511546 shares of BeiGene, Ltd. for $333.3M.

Biography of BAKER BROS. ADVISORS LP

No biography is available at this moment.

2024-08-20PurchaseKymera Therapeutics, Inc.
KYMR
director
1
<0.0001%
$46.41$46+0.03%
2024-03-28PurchaseIGM Biosciences, Inc.
IGMS
97,473
0.1653%
$9.62$937,632-0.62%
2024-03-27PurchaseIGM Biosciences, Inc.
IGMS
27,844
0.0472%
$9.24$257,170+3.56%
2024-03-26PurchaseIGM Biosciences, Inc.
IGMS
270,000
0.4372%
$8.26$2.23M+10.48%
2023-12-15PurchaseIGM Biosciences, Inc.
IGMS
288,007
0.5123%
$6.55$1.89M+60.76%
2023-12-14PurchaseIGM Biosciences, Inc.
IGMS
157,370
0.2689%
$6.50$1.02M+56.08%
2023-12-14PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
20,633
0.102%
$228.32$4.71M+0.82%
2023-12-13PurchaseIGM Biosciences, Inc.
IGMS
87,316
0.1427%
$5.96$520,776+62.86%
2023-12-13PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
81,159
0.3998%
$219.39$17.81M+4.63%
2023-12-12PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
34,578
0.1727%
$218.31$7.55M+6.5%
2023-11-21PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
64,350
0.3268%
$188.47$12.13M+24.51%
2023-11-20PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
20,709
0.1027%
$185.74$3.85M+23.63%
2023-11-17PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
46,370
0.233%
$174.70$8.1M+33.42%
2023-11-15PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
15,199
0.0766%
$161.97$2.46M+42.83%
2023-11-14SaleBeiGene, Ltd.
BGNE
1.1M
0.9291%
$180.50$198.55M-17.11%
2023-11-14PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
71,848
0.361%
$155.15$11.15M+49.6%
2023-11-13PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
69,839
0.3486%
$143.21$10M+60.06%
2023-06-26PurchaseIGM Biosciences, Inc.
IGMS
director
5.63M
–
$0$0-7.21%
2023-05-24PurchaseACADIA Pharmaceuticals Inc.
ACAD
294,154
0.179%
$25.33$7.45M-6.43%
2023-05-24PurchaseACADIA Pharmaceuticals Inc.
ACAD
553,263
0.3387%
$25.48$14.1M-6.43%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.